Skip to main content

Table 2 Comparison of symptom scores between Ludangshen and placebo group

From: Ludangshen oral liquid for treatment of convalescent COVID-19 patients: a randomized, double-blind, placebo-controlled multicenter trial

Variables

FAS analysis

PPS analysis

 

Ludangshen

Placebo

P value

Ludangshen

Placebo

P value

Fatigue (n)

94

90

 

92

92

 

 Week 1

2.88 ± 1.44

3.64 ± 1.43

 < 0.001

2.87 ± 1.45

3.51 ± 1.55

 < 0.001

 Week 2

1.31 ± 1.42

3.21 ± 1.85

 < 0.001

1.35 ± 1.46

3.11 ± 1.92

 < 0.001

Anorexia (n)

68

70

 

67

68

 

 Week 1

1.66 ± 1.17

2.61 ± 1. 53

 < 0.001

1.66 ± 1.74

2.62 ± 1.55

0.535

 Week 2

0.78 ± 1.22

2.09 ± 1.74

 < 0.001

0.78 ± 1.23

2.09 ± 1.76

 < 0.001

Distention (n)

43

34

 

42

43

 

 Week 1

2.02 ± 1.88

2.32 ± 2.10

0.024

2.00 ± 1. 90

2.27 ± 2.11

0.619

 Week 2

0.74 ± 1.62

1.53 ± 1.89

0.987

0.74 ± 1.64

1.58 ± 1.90

0.341

Loose stools (n)

48

52

 

48

50

 

 Week 1

2.02 ± 1.77

2.65 ± 1.94

0.001

2.02 ± 1.77

2.70 ± 1.96

0.749

 Week 2

1.04 ± 1.91

2.12 ± 2.37

0.001

1.04 ± 1.91

2.20 ± 2.37

0.001

Shortness of breath (n)

50

50

 

49

49

 

 Week 1

3.40 ± 1.36

4.02 ± 1.65

0.016

3.43 ± 1.35

4.02 ± 1.66

0.996

 Week 2

1.76 ± 1.38

3.26 ± 2.07

< 0.001

1.78 ± 1.396

3.27 ± 2.09

 < 0.001

  1. FAS full analysis set, PPS per protocol set